Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-12

Clinical Trial Update: Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine [NA]

View source ↗

Summary

A completed clinical trial evaluated milnacipran for reducing pain in individuals with chronic migraine; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milnacipran (milnacipran)

Snippet

Sponsor: Timothy Smith | Conditions: Chronic Migraine | NA | Status: COMPLETED | Results posted: 2022-08-12